跳至主要内容
临床试验/NCT01568931
NCT01568931Unknown4 期

Local Delivery of thrombolytIcs Before Thrombectomy in patientS With ST-elevatiOn myocardiaL Infarction Undergoing Primary percuTaneous Coronary interventION - The DISSOLUTION Randomized Trial

University of Roma La Sapienza0 个研究点目标入组 100 人开始时间: 2014年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
100
主要终点
Outcomes at 30 days

研究概览

简要总结

Background Prompt reperfusion with percutaneous coronary intervention (PCI) in the setting of ST-elevation myocardial infarction (STEMI) improves clinical outcomes through salvage of myocardial tissue.

Although the use of thrombus aspiration with PCI can result in improved rates of normal epicardial flow and myocardial perfusion, several unmet needs remain.

Purpose The purpose of this trial will be to evaluate the hypothesis that local delivery of thrombolytics vs. saline infusion prior to thrombus aspiration and PCI is safe and effective in patients with STEMI.

详细描述

The study will select patients with ST-elevation myocardial infarction (STEMI) with angiographic evidence of massive thrombosis in the culprit artery undergoing manual thrombectomy followed by primary percutaneous coronary intervention (PCI).

Patients will be randomized to receive local bolus of 200,000 units urokinase or saline solution

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ST-elevation myocardial infarction
  • angiographic evidence of massive thrombosis in the culprit artery
  • Indication to manual thrombectomy followed by primary percutaneous coronary intervention (PCI)
  • Able to understand and willing to sign the informed CF

排除标准

  • Women of child bearing potential patients must demonstrate a negative pregnancy test performed within 24 hours before CT

研究组 & 干预措施

Urokinase

Active Comparator

Patients will be randomized to to receive local bolus of 200,000 units urokinase

干预措施: Urokinase (Drug)

Saline

Active Comparator

Patients will be randomized to to receive local bolus of intracoronary saline

干预措施: Saline (Drug)

结局指标

主要结局

Outcomes at 30 days

时间窗: Up to 30 days

30-day occurrence of death, new Q-wave myocardial infarction, coronary artery bypass grafting, target lesion revascularization, stroke, or stent thrombosis

次要结局

  • Left ventricular remodeling(Up to 1 year after Primary PCI)
  • Myocardial reperfusion after Primary CI(Up to 90 minutes after Primary PCI)
  • 5-year MACE(Up to 5 years after Primary PCI)

研究者

发起方
University of Roma La Sapienza
申办方类型
Other
责任方
Principal Investigator
主要研究者

Francesco Pelliccia

Assistant Professor

University of Roma La Sapienza

相似试验

Local Thrombolytics Before Thrombectomy in STEMI | 临床试验